Tracy Hussell
Has grant
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Open
Immunomatrix in Complex Disease (ICD)
Open Date: 2020-10-01
Close Date: 2028-09-30
Grant: Close
Role of STAT1 Cooperative DNA Binding in Interferon Signalling
Open Date: 2013-07-31
Close Date: 2016-07-30
Grant: Close
Innate immune parameters leading to virus-induced secondary bacterial pneumonia and sepsis.
Open Date: 2010-12-01
Close Date: 2013-11-30
Grant: Close
Development of a viral exacerbation model of allergic asthma
Open Date: 2008-06-30
Close Date: 2008-12-31
Grant: Close
Innate priming and the immunopathogenesis of lung co-infections
Open Date: 2005-08-31
Close Date: 2008-11-30
Articles (18)
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2025
Airborne fungi are potent inducers of respiratory disease and cause the debilitating conditions severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA). However, the immune cell types and the inflammatory airway environment that defines SAFS and ABPA patients is not extensively characterised. To address this, we recruited SAFS and ABPA patients, asthmatics without evidence of fungal sensitisation and healthy controls (n= 20 individuals per group). Immune cells were isolated from collected sputum and peripheral blood samples and immunophenotyping was performed via flow cytometry. By applying a machine learning approach to our dataset, we identify a critical association between CD4 + T cells, type 2 conventional dendritic cells, eosinophils, proinflammatory factors and severe respiratory disease. These complex immune signatures should be investigated further to improve the diagnostics and treatment of SAFS and ABPA. Graphical abstract
Year:
2025
Collagen deposition in fibroblasts, the primary collagen-producing cells, is regulated by both macrophages and the circadian rhythm, although how these regulatory processes interact with one another is unknown. Here, we reveal that macrophage-fibroblast interaction enhances collagen deposition which requires a functional circadian rhythm. This response is also dependent on macrophage polarisation status, where M0 (naïve) and M1 (pro-inflammatory) macrophages require direct cell-cell contact; whereas M2 (anti-inflammatory) macrophages utilise an additional mechanism through secreted soluble factors that strengthen circadian rhythms and significantly increase collagen deposition in fibroblasts, independent of cell-cell contact. Using mass spectrometry proteomics analysis, we identified PDGFA as a key factor in induction of circadian amplitude in fibroblasts. Crucially, macrophages lacking PDGFA showed diminished ability to modulate fibroblast circadian rhythms and collagen production. Further, in fibroblasts with impaired circadian rhythms, neither macrophages nor macrophage-secreted factors are capable of inducing collagen deposition. These results confirmed that the collagen secretory pathway is also under circadian clock control in lung fibroblasts, and demonstrated that macrophages influence collagen deposition via circadian clock mediated mechanisms. In conclusion, our findings highlight M2-derived PDGFA as a key macrophage-derived factor in extracellular matrix remodelling.
Year:
2025
Year:
2024
Even within a single protein, antibody binding can have beneficial, neutral, or harmful effects during the response to infection. Resolving a polyclonal antibody repertoire across a pathogen’s proteome to specific epitopes may therefore explain much of the heterogeneity in susceptibility to infectious disease. However, the three-dimensional nature of antibody-epitope interactions makes the discovery of non-obvious targets challenging. We implemented a novel computational method and synthetic biology pipeline for identifying epitopes that are functionally important in the SARS-CoV-2 proteome and identified an IgM-dominant response to an exposed Membrane protein epitope which to our knowledge is the strongest correlate of severe disease identified to date (adjusted OR 72.14, 95% CI: 9.71 – 1300.15), stronger even than the exponential association of severe disease with age. We also identify persistence (> 2 years) of this IgM response in individuals with longCOVID, and a correlation with fatigue and depression symptom burden. The repetitive arrangement of this epitope and the pattern of isotype class switching is consistent with this being a previously unrecognized T independent antigen. These findings point to a coronavirus host-pathogen interaction characteristic of severe virus driven immune pathology. This epitope is a promising vaccine and therapeutic target as it is highly conserved through SARS-CoV-2 variant evolution in humans to date and in related coronaviruses (e.g. SARS-CoV), showing far less evolutionary plasticity than targets on the Spike protein. This provides a promising biomarker for longCOVID and a target to complement Spike-directed vaccination which could broaden humoral protection from severe or persistent disease or novel coronavirus spillovers.
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Collaborators (48)
Susanna Dunachie
Professor at University of Oxford
University of Oxford
Iashia Nabi
The University of Manchester
Rachel Lennon
The University of Manchester
Anna Nicolaou
The University of Manchester
Timo Hautala
Professor in microbiology and immunology
University of Oulu
Karl Kadler
The University of Manchester
Megan Sutcliffe
The University of Manchester
Sofie Eg Jørgensen
Assistant professor
Aarhus University
Patrick Kearns
ECAT/Wellcome Trust Clinical Lecturer
University of Edinburgh
Jean-Marc Schwartz
The University of Manchester
Tracy Briggs
The University of Manchester
Gaia Gestri
University College London
John Grainger
The University of Manchester
Pilar Rivera-Ortega
Associate Research and Development Director
Manchester University NHS Foundation Trust
David Cavanagh
Senior Lecturer
University of Edinburgh
Julian Knight
University of Oxford
Teresa Lambe
University of Oxford
Tomohiko Yamamura
assistant professor
Kobe University
Ben Mulhearn
The University of Manchester
Peter Cook
University of Exeter
Paul Dark
Professor of Critical Care
The University of Manchester
Douglas Dyer
The University of Manchester
Karen Piper Hanley
The University of Manchester
David Denning
Professor of Infectious Diseases in Global Health
The University of Manchester
Joseph Marsh
University of Edinburgh
Gabriella Lindergard
Clinical Lecturer in Nursing (NIHR-ICAT)
The University of Manchester
Nick Gilbert
Principal Investigator
University of Edinburgh
Stephen Carter
Lecturer (Teaching)
University College London
Sean Knight
The University of Manchester
Angela Simpson
The University of Manchester
Philip D. King
University of Michigan Medical School
Alexander Mentzer
Principal Investigator / Clinical Research Scientist
University of Oxford
Christopher E. M. Griffiths
The University of Manchester
Grant Stewart
Professor of Cancer Genetics
University of Birmingham
Matthew Hepworth
The University of Manchester
Andrew S MacDonald
The University of Manchester
Magnus Rattray
The University of Manchester
Matthew Guille
Academic, Professor, Professor of Developmental Genetics
University of Portsmouth
Joan Chang
Senior Research Fellow
The University of Manchester
Qing Jun Meng
The University of Manchester
Christine Chew
Academic , NIHR Academic Clinical Lecturer in Paediatrics
University of Bristol
Alexander Eckersley
The University of Manchester
Nicholas Scott
The University of Manchester
Susan Rosser
Professor of Synthetic Biology
University of Edinburgh
Stefano Adriano Colombo
The University of Manchester
William Gordon Charles Horsnell
Professor
University of Exeter
Madhvi Menon
The University of Manchester
Laurence Pearmain
The University of Manchester
Make your next move.
Prepare your application
Review drafts before you send them.